03.06.2008 2:42 pm
Singulex, Novartis team up to test drugs
St. Louis Post-Dispatch
Singulex Inc., which has its research base in St. Louis, said Thursday its biomarker technology is being used by Swiss drug giant Novartis AG in developing and evaluating pharmaceutical treatments.
Terms of the deal were not disclosed.
Novartis will use Singulex’ Erenna…
- Comments Off
- Email this
